<DOC>
	<DOCNO>NCT02554708</DOCNO>
	<brief_summary>To assess safety efficacy pCONus treatment wide neck bifurcation aneurysm .</brief_summary>
	<brief_title>pCONus Treatment Wide Neck Intracranial Aneurysms</brief_title>
	<detailed_description>Title : pCONus Treatment Wide Neck Intracranial Aneurysms Acronym : pToWin Device : pCONus Bifurcation Aneurysm Implant Study design : Prospective , multicenter , single-arm clinical investigation Purpose : To assess safety efficacy pCONus treatment wide neck bifurcation aneurysm Duration study : 30 month Sample size : 100 patient Number site : &gt; 20 Follow-up interval : 6 12 month clinical follow-up</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>1 . Aneurysm status : Unruptured aneurysm Ruptured aneurysm Hunt Hess grade I III . 2 . Age ≥18 ≤ 80 year . 3 . The patient legal representative provide write informed consent . 4 . The patient show general compliance follow medical regimen attend followup examination . 5 . The target aneurysm locate one follow cerebral vessel bifurcation : ICA terminus , AcomA , MCA BA . 6 . Bifurcation wide neck aneurysm . 7 . The dome height allow safe deployment device crown . The fundus aneurysm offer enough space crown pCONus deploy . 1 . Vessel tortuosity preclude safe access device deployment . 2 . Stenosis within vascular access target vessel ≥ 50 % . 3 . The target aneurysm previously treat stent intraaneurysmal implant beside coil . 4 . The treatment plan target aneurysm include use additional intra and/or extraaneurysmal temporary permanent implant coil . 5 . More one intracerebral aneurysm require treatment within follow 6 month . 6 . Imaging evidence arteriovenous cerebrovascular malformation dural fistula . 7 . Any physical , medical psychiatric condition patient interfere adherence requirement followup regimen study . 8 . Any neurological disorder progressive neurological symptom , except attributable compressive effect target aneurysm . 9 . Current involvement another study trial . 10 . Women child bear potential breastfeeding provide negative pregnancy test . 11 . Known allergy component device , study medication contrast medium control medically . 12 . A medical condition interfere dual antiplatelet treatment . 13 . Known coagulopathy . 14 . Intracranial hemorrhage past 30 day apart target aneurysm . 15 . Ischemic stroke past 30 day . 16 . Myocardial infarction past 30 day . 17 . Major surgery past 30 day . 18 . Evidence active infection time treatment . 19 . Co morbidity condition life expectancy le 12 month . 20 . Additional Exclusion criterion rupture aneurysm acute phase : 1 . The patient clinically severely affected ( Hunt Hess grade IV V ) . 2 . Severe vasospasm proven angiography . 3 . Proven parenchymal hemorrhage CT MRI . 4 . Proven subdural hematoma CT MRI .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>bifurcation</keyword>
	<keyword>wide neck</keyword>
	<keyword>pCONus</keyword>
	<keyword>intracerebral</keyword>
	<keyword>stroke</keyword>
</DOC>